These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans. Valenzuela-Fernández A; Palanche T; Amara A; Magerus A; Altmeyer R; Delaunay T; Virelizier JL; Baleux F; Galzi JL; Arenzana-Seisdedos F J Biol Chem; 2001 Jul; 276(28):26550-8. PubMed ID: 11352904 [TBL] [Abstract][Full Text] [Related]
44. The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor. Mosi RM; Anastassova V; Cox J; Darkes MC; Idzan SR; Labrecque J; Lau G; Nelson KL; Patel K; Santucci Z; Wong RS; Skerlj RT; Bridger GJ; Huskens D; Schols D; Fricker SP Biochem Pharmacol; 2012 Feb; 83(4):472-9. PubMed ID: 22146583 [TBL] [Abstract][Full Text] [Related]
45. Andrograpanin, a compound isolated from anti-inflammatory traditional Chinese medicine Andrographis paniculata, enhances chemokine SDF-1alpha-induced leukocytes chemotaxis. Ji LL; Wang Z; Dong F; Zhang WB; Wang ZT J Cell Biochem; 2005 Aug; 95(5):970-8. PubMed ID: 15937916 [TBL] [Abstract][Full Text] [Related]
46. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362 [TBL] [Abstract][Full Text] [Related]
47. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity. Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575 [TBL] [Abstract][Full Text] [Related]
48. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization. Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202 [TBL] [Abstract][Full Text] [Related]
49. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. Murakami T; Zhang TY; Koyanagi Y; Tanaka Y; Kim J; Suzuki Y; Minoguchi S; Tamamura H; Waki M; Matsumoto A; Fujii N; Shida H; Hoxie JA; Peiper SC; Yamamoto N J Virol; 1999 Sep; 73(9):7489-96. PubMed ID: 10438838 [TBL] [Abstract][Full Text] [Related]
50. The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. Saini V; Staren DM; Ziarek JJ; Nashaat ZN; Campbell EM; Volkman BF; Marchese A; Majetschak M J Biol Chem; 2011 Sep; 286(38):33466-77. PubMed ID: 21757744 [TBL] [Abstract][Full Text] [Related]
51. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection. Cabrera C; Gutiérrez A; Blanco J; Barretina J; Litovchick A; Lapidot A; Evdokimov AG; Clotet B; Esté JA AIDS Res Hum Retroviruses; 2000 May; 16(7):627-34. PubMed ID: 10791873 [TBL] [Abstract][Full Text] [Related]
52. Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors. Wu CH; Wang CJ; Chang CP; Cheng YC; Song JS; Jan JJ; Chou MC; Ke YY; Ma J; Wong YC; Hsieh TC; Tien YC; Gullen EA; Lo CF; Cheng CY; Liu YW; Sadani AA; Tsai CH; Hsieh HP; Tsou LK; Shia KS J Med Chem; 2015 Feb; 58(3):1452-65. PubMed ID: 25584630 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116 [TBL] [Abstract][Full Text] [Related]
54. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Chen X; Yang L; Zhang N; Turpin JA; Buckheit RW; Osterling C; Oppenheim JJ; Howard OM Antimicrob Agents Chemother; 2003 Sep; 47(9):2810-6. PubMed ID: 12936978 [TBL] [Abstract][Full Text] [Related]
55. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Zhou N; Luo Z; Luo J; Hall JW; Huang Z Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178 [TBL] [Abstract][Full Text] [Related]
56. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Chen X; Beutler JA; McCloud TG; Loehfelm A; Yang L; Dong HF; Chertov OY; Salcedo R; Oppenheim JJ; Howard OM Clin Cancer Res; 2003 Aug; 9(8):3115-23. PubMed ID: 12912963 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. De Clercq E; Schols D Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685 [TBL] [Abstract][Full Text] [Related]